Review links lifestyle and the ECS in MS, but finds no proven…
Modulation of the endocannabinoid system through diet, physical activity and microbiome in the new era of multiple sclerosis.
AI Summary
This review asks how diet, physical activity, and the gut microbiome may relate to the endocannabinoid system (ECS) in multiple sclerosis (MS), drawing on preclinical and clinical evidence. It concludes that cannabinoid-based medicines have an established role mainly in symptom relief, particularly for residual symptoms associated with spasticity, while proposed effects on neuroinflammation and nerve-cell injury rely largely on mechanistic and preclinical findings.
The review describes biologically plausible links: physical activity can raise circulating anandamide in healthy people, and dietary components and gut microbes may affect ECS-related pathways. But direct evidence that these changes produce ECS-mediated clinical effects in MS is limited, and the review does not establish that lifestyle changes modify the disease. As an abstract-based summary, its central limitation is that it presents a hypothesis-generating framework, not proof of causal mediation or disease-modifying efficacy.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
Meta-analysis finds shared endocannabinoid gene changes across myopathies
Small biomarker analysis finds no significant changes after 10 HBOT sessions
Rat study finds mixed behavioral and biological effects of WIN under chronic…
Explore More Research
Stay informed about the latest cannabis science.